| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/17/1997 | US5639950 Nucleotide sequence encoding for bifunctional enzyme for proline production |
| 06/17/1997 | US5639949 Genes for the synthesis of antipathogenic substances |
| 06/17/1997 | US5639948 Restoring fertility to plants |
| 06/17/1997 | US5639947 Genetic engineering |
| 06/17/1997 | US5639940 Production of fibrinogen in transgenic animals |
| 06/17/1997 | US5639876 Encoding protein capable of selectively binding to immune serum which inhibits helminth development |
| 06/17/1997 | US5639873 Oligothionucleotides |
| 06/17/1997 | US5639872 Human VEGF-specific oligonucleotides |
| 06/17/1997 | US5639870 Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 06/17/1997 | US5639868 Rna containing 2'-deoxy-2'-amine pyrimidene nucleotides |
| 06/17/1997 | US5639863 Isolated dna which codes for a variable region of the antibody which is active against glioma antigen |
| 06/17/1997 | US5639862 A heparin-binding secretory transforming factor (hst-1) polypeptide lacking from 1 to 47 continuous amino acid residues from the amino-terminal end; wound healing agents |
| 06/17/1997 | US5639858 Polypeptide |
| 06/17/1997 | US5639856 Proteins that are modulators of nerve cell growth and regeneration |
| 06/17/1997 | US5639855 Adrenomedullin |
| 06/17/1997 | US5639854 Amino acid sequence of a t-cell epitope of the gag protein of hiv-1; vaccines |
| 06/17/1997 | US5639853 Respiratory syncytial virus vaccines |
| 06/17/1997 | US5639794 Use of saponin in methods and compositions for pathogen control |
| 06/17/1997 | US5639790 Plant medium-chain thioesterases |
| 06/17/1997 | US5639736 Reducing neovascularization by administering through the eye |
| 06/17/1997 | US5639728 Antineoplastic peptide |
| 06/17/1997 | US5639727 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/17/1997 | US5639725 Angiostatin protein |
| 06/17/1997 | US5639664 A transformant; genetic engineering |
| 06/17/1997 | US5639663 Encodes beta-glucuronidase activity, and is linked to second gene which encodes neomycin phosphotransferase activity |
| 06/17/1997 | US5639661 Genes and proteins for treating cystic fibrosis |
| 06/17/1997 | US5639660 Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE |
| 06/17/1997 | US5639655 PML-RARA targeted ribozymes |
| 06/17/1997 | US5639652 Nucleic acid encoding serotonin |
| 06/17/1997 | US5639651 Gap-related gene, human IQGAP1 |
| 06/17/1997 | US5639650 cDNA clone for South African Arbovirus No. 86 |
| 06/17/1997 | US5639649 Polio virus mutants; vaccines |
| 06/17/1997 | US5639647 2'-deoxy-2'alkylnucleotide containing nucleic acid |
| 06/17/1997 | US5639645 Genetic engineering |
| 06/17/1997 | US5639644 Plasmid derived from Lactobacillus elbrueckii Sp. |
| 06/17/1997 | US5639642 Synthetic leader peptide sequences |
| 06/17/1997 | US5639641 Resurfacing of rodent antibodies |
| 06/17/1997 | US5639640 Polypeptide |
| 06/17/1997 | US5639639 Transforming a eukaryotic cell by inserting vector with dna coding for each of two subunits of hormone; culturing; expression |
| 06/17/1997 | US5639638 DNA molecules encoding bone morpogenetic protein-11 |
| 06/17/1997 | US5639637 Pure protein free of blood products comprising a sequence of variant hepatitis b s protein, said protein comprising a modified a determinant of an s protein in which amino acid at position 145 is arginine |
| 06/17/1997 | US5639635 Process for bacterial production of polypeptides |
| 06/17/1997 | US5639634 Useful for diagnosing tumors and targeting drug delivery |
| 06/17/1997 | US5639622 Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof |
| 06/17/1997 | US5639621 Immunoreactive with a polymorphic epithelial mucin antigen |
| 06/17/1997 | US5639619 Screening assay for anti-HIV drugs using the Vpr gene |
| 06/17/1997 | US5639618 Method of isolating a lineage specific stem cell in vitro |
| 06/17/1997 | US5639617 Determining concentration of procalcitonin in biological fluids to diagnose infections or monitor treatment |
| 06/17/1997 | US5639616 Isolated nucleic acid encoding a ubiquitous nuclear receptor |
| 06/17/1997 | US5639612 Selecting first probe based upon its melting temperature at a sodium and formamide concentration of analyte, hybridizing analyte between second probe and immobilized first probe, detecting second probe |
| 06/17/1997 | US5639609 Method for immobilizing nucleic acids using modified capture probes |
| 06/17/1997 | US5639607 Digesting dna with restriction endonuclease which recognises the dna sequence at the site of polymorphism being able to cleave at the site ala-d2 of 5-aminolevulinate dehydrogenae gene which is not present in ala-d1 allele |
| 06/17/1997 | US5639606 Method for quantitative measurement of gene expression using multiplex competitive reverse transcriptase-polymerase chain reaction |
| 06/17/1997 | US5639605 Human interleukin-3 receptor component |
| 06/17/1997 | US5639600 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 06/17/1997 | US5639599 Centrifuging, separating, lysing, exposing to sound waves, complexing and amplifying by polymerase chain reaction |
| 06/17/1997 | US5639597 Specific, sensitive |
| 06/17/1997 | US5639596 DNA construct and in vitro test for detecting tumor promoters by means of said DNA construct |
| 06/17/1997 | US5639595 Identification of novel drugs and reagents |
| 06/17/1997 | US5639594 Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis |
| 06/17/1997 | US5639505 Applying a glassy carbohydrate film containing sugars and an allosteric effector on the substrate; reduced surface energy |
| 06/17/1997 | US5639462 Attenuated polyiviruses vaccine containing them and vaccination methods using them |
| 06/17/1997 | US5639457 Introducing dna sequence coding for rearranged antibody into male pronucleus of fertilized ovum; implanting in pig or rabbit; transgenic offspring produce antibodies |
| 06/17/1997 | US5639455 Immunosuppressant |
| 06/17/1997 | US5639453 Therapeutic uses of IL-3 |
| 06/17/1997 | US5639440 Administering mixture of polypeptide and immunogen to transgenic mammal having tolerance for polypeptide yields antibody capable of binding immunogen |
| 06/17/1997 | US5639423 Chamber with thin film wall with element on wall for manipulation of parameter of chemical reaction |
| 06/17/1997 | US5639275 Capsule containing genetically engineered cells |
| 06/16/1997 | CA2279675A1 Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279673A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses |
| 06/16/1997 | CA2279669A1 Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| 06/16/1997 | CA2192738A1 Truncated form of inhibitory kappa b protein (lkb), recombinant production and uses thereof |
| 06/16/1997 | CA2190304A1 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 06/12/1997 | WO1997020950A1 Improved circular site-directed mutagenesis |
| 06/12/1997 | WO1997020948A1 A cascade nucleic acid amplification reaction |
| 06/12/1997 | WO1997020943A1 Regulated protein expression in stably transfected mammalian cells |
| 06/12/1997 | WO1997020942A1 Hsd17b1 promoter, enhancer, silencer and use thereof |
| 06/12/1997 | WO1997020941A1 Constructs and methods for enhancing protein levels in photosynthetic organisms |
| 06/12/1997 | WO1997020940A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 06/12/1997 | WO1997020938A2 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 06/12/1997 | WO1997020937A2 Modification process |
| 06/12/1997 | WO1997020936A1 Modification of starch synthesis in plants |
| 06/12/1997 | WO1997020935A2 Viral vectors |
| 06/12/1997 | WO1997020934A1 Transferrin binding proteins of pasteurella haemolytica and vacc ines containing same |
| 06/12/1997 | WO1997020933A2 MUTATIONAL VARIANTS OF MAMMALIAN Ob GENE PROTEINS |
| 06/12/1997 | WO1997020932A1 Specific binding members for human carcinoembryonic antigen, materials and methods |
| 06/12/1997 | WO1997020931A1 Method and compositions for monitoring dna binding molecules in living cells |
| 06/12/1997 | WO1997020930A1 Urogenital sinus derived growth factor nucleotide and amino acid sequences |
| 06/12/1997 | WO1997020929A1 Fibroblast growth factor fgf-10 |
| 06/12/1997 | WO1997020928A1 Novel semaphorin z and gene encoding the same |
| 06/12/1997 | WO1997020927A1 Compounds having lectin properties and biological uses thereof |
| 06/12/1997 | WO1997020926A1 Il-13 receptor polypeptide |
| 06/12/1997 | WO1997020925A1 Modified vegf antisense oligonucleotides for treatment of skin disorders |
| 06/12/1997 | WO1997020924A1 A class of oligonucleotides, therapeutically useful as antitumoural agents |
| 06/12/1997 | WO1997020923A1 Preparation of a multicombinatorial library of antibody gene expression vectors |
| 06/12/1997 | WO1997020922A1 Thermolabile uracil-dna-glycosylase, process for its preparation and use for removing uracil from dna |
| 06/12/1997 | WO1997020919A1 Materials and methods for converting dna to co-dna |
| 06/12/1997 | WO1997020918A1 Method of screening for enzyme activity |
| 06/12/1997 | WO1997020917A2 Dna encoding phage abortive infection protein from lactococcus lactis, and method of use thereof |
| 06/12/1997 | WO1997020858A1 Apoptosis induced by monoclonal antibody anti-her2 |